Targeting RNA to treat neuromuscular disease.
The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considerable challenges: skeletal muscle is the most abundant tissue in the body, and many neuromuscular disorders are multisystemic conditions. However, despite these barriers...
Үндсэн зохиолчид: | Muntoni, F, Wood, M |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2011
|
Ижил төстэй зүйлс
-
RNA-targeted splice-correction therapy for neuromuscular disease.
-н: Wood, M, зэрэг
Хэвлэсэн: (2010) -
Syncoilin upregulation in muscle of patients with neuromuscular disease.
-н: Brown, S, зэрэг
Хэвлэсэн: (2005) -
Splicing therapy for neuromuscular disease.
-н: Douglas, A, зэрэг
Хэвлэсэн: (2013) -
Syncoilin expression in neuromuscular disorders
-н: Torelli, S, зэрэг
Хэвлэсэн: (2001) -
Syncoilin expression in neuromuscular disorders.
-н: Howman, E, зэрэг
Хэвлэсэн: (2001)